APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Diagnostics

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Selected research

Market Analysis & Forecast

Global Influenza Diagnostics Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchInfluenza Diagnostics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Influenza Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

Read the full market overview

Report Includes

This report presents an overview of global market for Influenza Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Influenza Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Influenza Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Influenza Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Influenza Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Influenza Diagnostics Segment by Company

BD

Abbott (Include Alere)

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Influenza Diagnostics Segment by Type

RIDT

RT-PCR

Cell Culture

Others

Influenza Diagnostics Segment by Application

Hospitals

POCT

Others

Influenza Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Influenza Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Influenza Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RIDT Major Player Table 3. RT-PCR Major Player Table 4. Cell Culture Major Player Table 5. Others Major Player Table 6. Global Influenza Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. POCT Major Player Table 9. Others Major Player Table 10. Influenza Diagnostics Industry Trends Table 11. Influenza Diagnostics Industry Drivers Table 12. Influenza Diagnostics Industry Opportunities and Challenges Table 13. Influenza Diagnostics Industry Restraints Table 14. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Influenza Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Influenza Diagnostics Market Share by Region (2021-2026) Table 17. Global Influenza Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Influenza Diagnostics Market Share by Region (2027-2032) Table 19. Global Influenza Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Influenza Diagnostics Revenue Market Share by Players (2021-2026) Table 21. Global Influenza Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Influenza Diagnostics Key Players Headquarters & Area Served Table 23. Global Influenza Diagnostics Players, Product Type & Application Table 24. Global Influenza Diagnostics Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Influenza Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Influenza Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Influenza Diagnostics Revenue Market Share by Type (2021-2026) Table 31. Global Influenza Diagnostics Revenue Market Share by Type (2027-2032) Table 32. Global Influenza Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Influenza Diagnostics Revenue Market Share by Application (2021-2026) Table 36. Global Influenza Diagnostics Revenue Market Share by Application (2027-2032) Table 37. BD Company Information Table 38. BD Business Overview Table 39. BD Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BD Influenza Diagnostics Product Portfolio Table 41. BD Recent Development Table 42. Abbott (Include Alere) Company Information Table 43. Abbott (Include Alere) Business Overview Table 44. Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Abbott (Include Alere) Influenza Diagnostics Product Portfolio Table 46. Abbott (Include Alere) Recent Development Table 47. Roche Company Information Table 48. Roche Business Overview Table 49. Roche Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Roche Influenza Diagnostics Product Portfolio Table 51. Roche Recent Development Table 52. SIEMENS Company Information Table 53. SIEMENS Business Overview Table 54. SIEMENS Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. SIEMENS Influenza Diagnostics Product Portfolio Table 56. SIEMENS Recent Development Table 57. Analytik Jena Company Information Table 58. Analytik Jena Business Overview Table 59. Analytik Jena Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Analytik Jena Influenza Diagnostics Product Portfolio Table 61. Analytik Jena Recent Development Table 62. Quidel Company Information Table 63. Quidel Business Overview Table 64. Quidel Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Quidel Influenza Diagnostics Product Portfolio Table 66. Quidel Recent Development Table 67. Thermo Fisher Company Information Table 68. Thermo Fisher Business Overview Table 69. Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Thermo Fisher Influenza Diagnostics Product Portfolio Table 71. Thermo Fisher Recent Development Table 72. Meridian Bioscience Company Information Table 73. Meridian Bioscience Business Overview Table 74. Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Meridian Bioscience Influenza Diagnostics Product Portfolio Table 76. Meridian Bioscience Recent Development Table 77. BioMerieux Company Information Table 78. BioMerieux Business Overview Table 79. BioMerieux Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. BioMerieux Influenza Diagnostics Product Portfolio Table 81. BioMerieux Recent Development Table 82. Sekisui Diagnostics Company Information Table 83. Sekisui Diagnostics Business Overview Table 84. Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Sekisui Diagnostics Influenza Diagnostics Product Portfolio Table 86. Sekisui Diagnostics Recent Development Table 87. Response Biomedical Company Information Table 88. Response Biomedical Business Overview Table 89. Response Biomedical Influenza Diagnostics Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 90. Response Biomedical Influenza Diagnostics Product Portfolio Table 91. Response Biomedical Recent Development Table 92. SA Scientific Company Information Table 93. SA Scientific Business Overview Table 94. SA Scientific Influenza Diagnostics Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 95. SA Scientific Influenza Diagnostics Product Portfolio Table 96. SA Scientific Recent Development Table 97. North America Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Influenza Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 103. North America Influenza Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 104. Europe Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Influenza Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 110. Europe Influenza Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 111. China Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 112. China Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 113. China Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 114. China Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 116. Asia Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 117. Asia Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 118. Asia Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Influenza Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Influenza Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 121. Asia Influenza Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 122. SAMEA Influenza Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 123. SAMEA Influenza Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 124. SAMEA Influenza Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 125. SAMEA Influenza Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 126. SAMEA Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. SAMEA Influenza Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 128. SAMEA Influenza Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Influenza Diagnostics Image Figure 2. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. RIDT Image Figure 5. RT-PCR Image Figure 6. Cell Culture Image Figure 7. Others Image Figure 8. Global Influenza Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Influenza Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. POCT Image Figure 12. Others Image Figure 13. Global Influenza Diagnostics Market Size (US$ Million) & (2021-2032) Figure 14. Global Influenza Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Influenza Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Influenza Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Influenza Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Influenza Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Influenza Diagnostics Revenue Market Share by Type (2021-2032) Figure 21. Global Influenza Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Influenza Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Influenza Diagnostics Revenue Market Share by Application (2021-2032) Figure 24. North America Influenza Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Influenza Diagnostics Revenue Share by Type (2021-2032) Figure 26. North America Influenza Diagnostics Revenue Share by Application (2021-2032) Figure 27. North America Influenza Diagnostics Revenue Share by Country (2021-2032) Figure 28. United States Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Influenza Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Influenza Diagnostics Revenue Share by Type (2021-2032) Figure 33. Europe Influenza Diagnostics Revenue Share by Application (2021-2032) Figure 34. Europe Influenza Diagnostics Revenue Share by Country (2021-2032) Figure 35. Germany Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Influenza Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Influenza Diagnostics Revenue Share by Type (2021-2032) Figure 45. China Influenza Diagnostics Revenue Share by Application (2021-2032) Figure 46. Asia Influenza Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Influenza Diagnostics Revenue Share by Type (2021-2032) Figure 48. Asia Influenza Diagnostics Revenue Share by Application (2021-2032) Figure 49. Asia Influenza Diagnostics Revenue Share by Region (2021-2032) Figure 50. Japan Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Influenza Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Influenza Diagnostics Revenue Share by Type (2021-2032) Figure 58. SAMEA Influenza Diagnostics Revenue Share by Application (2021-2032) Figure 59. SAMEA Influenza Diagnostics Revenue Share by Country (2021-2032) Figure 60. Brazil Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Influenza Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • RIDT
  • RT-PCR
  • Cell Culture
  • Others
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbott (Include Alere)
  • Roche
  • SIEMENS
  • Analytik Jena
  • Quidel
  • Thermo Fisher
  • Meridian Bioscience
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Influenza Diagnostics Market by Type
  3. 1.2.1 Global Influenza Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RIDT
  5. 1.2.3 RT-PCR
  6. 1.2.4 Cell Culture
  7. 1.2.5 Others
  8. 1.3 Influenza Diagnostics Market by Application
  9. 1.3.1 Global Influenza Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 POCT
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Influenza Diagnostics Market Dynamics
  1. 2.1 Influenza Diagnostics Industry Trends
  2. 2.2 Influenza Diagnostics Industry Drivers
  3. 2.3 Influenza Diagnostics Industry Opportunities and Challenges
  4. 2.4 Influenza Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Influenza Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global Influenza Diagnostics Growth Trends by Region
  3. 3.2.1 Global Influenza Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Influenza Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global Influenza Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Influenza Diagnostics Revenue by Players
  2. 4.1.1 Global Influenza Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Influenza Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Influenza Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Influenza Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global Influenza Diagnostics Players, Product Type & Application
  8. 4.5 Global Influenza Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Influenza Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 Influenza Diagnostics Tier 1, Tier 2, and Tier 3
5 Influenza Diagnostics Market Size by Type
  1. 5.1 Global Influenza Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Influenza Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global Influenza Diagnostics Revenue Market Share by Type (2021-2032)
6 Influenza Diagnostics Market Size by Application
  1. 6.1 Global Influenza Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Influenza Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global Influenza Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BD
  2. 7.1.1 BD Company Information
  3. 7.1.2 BD Business Overview
  4. 7.1.3 BD Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BD Influenza Diagnostics Product Portfolio
  6. 7.1.5 BD Recent Developments
  7. 7.2 Abbott (Include Alere)
  8. 7.2.1 Abbott (Include Alere) Company Information
  9. 7.2.2 Abbott (Include Alere) Business Overview
  10. 7.2.3 Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbott (Include Alere) Influenza Diagnostics Product Portfolio
  12. 7.2.5 Abbott (Include Alere) Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Influenza Diagnostics Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 SIEMENS
  20. 7.4.1 SIEMENS Company Information
  21. 7.4.2 SIEMENS Business Overview
  22. 7.4.3 SIEMENS Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SIEMENS Influenza Diagnostics Product Portfolio
  24. 7.4.5 SIEMENS Recent Developments
  25. 7.5 Analytik Jena
  26. 7.5.1 Analytik Jena Company Information
  27. 7.5.2 Analytik Jena Business Overview
  28. 7.5.3 Analytik Jena Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Analytik Jena Influenza Diagnostics Product Portfolio
  30. 7.5.5 Analytik Jena Recent Developments
  31. 7.6 Quidel
  32. 7.6.1 Quidel Company Information
  33. 7.6.2 Quidel Business Overview
  34. 7.6.3 Quidel Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Quidel Influenza Diagnostics Product Portfolio
  36. 7.6.5 Quidel Recent Developments
  37. 7.7 Thermo Fisher
  38. 7.7.1 Thermo Fisher Company Information
  39. 7.7.2 Thermo Fisher Business Overview
  40. 7.7.3 Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Influenza Diagnostics Product Portfolio
  42. 7.7.5 Thermo Fisher Recent Developments
  43. 7.8 Meridian Bioscience
  44. 7.8.1 Meridian Bioscience Company Information
  45. 7.8.2 Meridian Bioscience Business Overview
  46. 7.8.3 Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Meridian Bioscience Influenza Diagnostics Product Portfolio
  48. 7.8.5 Meridian Bioscience Recent Developments
  49. 7.9 BioMerieux
  50. 7.9.1 BioMerieux Company Information
  51. 7.9.2 BioMerieux Business Overview
  52. 7.9.3 BioMerieux Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioMerieux Influenza Diagnostics Product Portfolio
  54. 7.9.5 BioMerieux Recent Developments
  55. 7.10 Sekisui Diagnostics
  56. 7.10.1 Sekisui Diagnostics Company Information
  57. 7.10.2 Sekisui Diagnostics Business Overview
  58. 7.10.3 Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sekisui Diagnostics Influenza Diagnostics Product Portfolio
  60. 7.10.5 Sekisui Diagnostics Recent Developments
  61. 7.11 Response Biomedical
  62. 7.11.1 Response Biomedical Company Information
  63. 7.11.2 Response Biomedical Business Overview
  64. 7.11.3 Response Biomedical Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Response Biomedical Influenza Diagnostics Product Portfolio
  66. 7.11.5 Response Biomedical Recent Developments
  67. 7.12 SA Scientific
  68. 7.12.1 SA Scientific Company Information
  69. 7.12.2 SA Scientific Business Overview
  70. 7.12.3 SA Scientific Influenza Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SA Scientific Influenza Diagnostics Product Portfolio
  72. 7.12.5 SA Scientific Recent Developments
8 North America
  1. 8.1 North America Influenza Diagnostics Revenue (2021-2032)
  2. 8.2 North America Influenza Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America Influenza Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America Influenza Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America Influenza Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America Influenza Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America Influenza Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America Influenza Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America Influenza Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America Influenza Diagnostics Revenue by Country
  11. 8.6.1 North America Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Influenza Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America Influenza Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Influenza Diagnostics Revenue (2021-2032)
  2. 9.2 Europe Influenza Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Influenza Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Influenza Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe Influenza Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Influenza Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Influenza Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Influenza Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe Influenza Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Influenza Diagnostics Revenue by Country
  11. 9.6.1 Europe Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Influenza Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Influenza Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Influenza Diagnostics Revenue (2021-2032)
  2. 10.2 China Influenza Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China Influenza Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China Influenza Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China Influenza Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China Influenza Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China Influenza Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China Influenza Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China Influenza Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Influenza Diagnostics Revenue (2021-2032)
  2. 11.2 Asia Influenza Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Influenza Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Influenza Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia Influenza Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Influenza Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Influenza Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Influenza Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia Influenza Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Influenza Diagnostics Revenue by Country
  11. 11.6.1 Asia Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Influenza Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Influenza Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Influenza Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA Influenza Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Influenza Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Influenza Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Influenza Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Influenza Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Influenza Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Influenza Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Influenza Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Influenza Diagnostics Revenue by Country
  11. 12.6.1 SAMEA Influenza Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Influenza Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Influenza Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst